hnRNPA2B1 is linked to several neurodegenerative disorders, yet its roles in the CNS have been largely unknown. In this issue of Neuron, Martinez et al. (2016) present the first transcriptome-wide analysis of hnRNPA2B1 targets and function in the nervous system.
Recent pathological and genetic evidence suggests that altered RNA processing is a central pathomechanism of several neurodegenerative diseases. First, a number of heterogenous nuclear ribonucleoproteins (hnRNPs) are mislocalized and aggregated in patients suffering from amyotrophic lateral sclerosis (ALS), the most frequent motor neuron disease, and frontotemporal dementia (FTD), a progressive disorder of personality, behavior, or language (Mackenzie et al., 2010) . In most ALS and FTD cases, the aggregating hnRNP is TAR DNA-binding protein of 43 kDa (TDP-43); a smaller number of cases feature aggregates that contain the related hnRNPs FUS, EWS, and TAF15. Second, point mutations in the genes encoding for TDP-43, FUS, hnRNPA1, and hnRNPA2B1 cause dominantly inherited forms of ALS or multisystem proteinopathy (MSP), a degenerative disorder affecting muscle, bone, brain, and motor neurons (Kim et al., 2013; Ling et al., 2013) . Moreover, several hnRNPs are sequestered by GGGGCC or CGG RNA repeats associated with ALS and fragile X-associated tremor/ ataxia syndrome (FXTAS), respectively (Ling et al., 2013) , and hnRNPA2/ B1 is depleted in entorhinal cortices of Alzheimer's disease patients (Berson et al., 2012) . Thus, dysfunctional hnRNPs appear to cause neurodegeneration-but how exactly do they do that? Is the loss of their normal physiological function toxic to neurons? Or do mislocalized or aggregated hnRNPs gain novel, toxic functions that are detrimental to neurons? How do diseaseassociated mutations affect hnRNP function, and which changes in neuronal mRNA processing do they bring about? Martinez et al. (2016) now address these key questions for hnRNPA2B1, whose function has so far mainly been studied in cancer cell lines and in vitro (Huelga et al., 2012) . They present the first transcriptome-wide compendium of hnRNPA2B1 RNA targets in the CNS, identified by three independent and complementary approaches: iCLIP from mouse spinal cord, eCLIP from iPSC-derived human motor neurons, and RNA-Bind-N-Seq (RBNS, an in vitro method using the recombinant RNAbinding domain of hnRNPA2B1 as a bait to pull down interacting RNA sequences from a randomized RNA pool). While there was little overlap in the identified RNA targets between mouse spinal cord and human iPSC-derived motor neurons, the authors identified a clear preference for UAG(G/A) motifs both in the iCLIP/eCLIP and in the RBNS data, consistent with a previous study (Huelga et al., 2012) . They found CLIP sites in >500 genes, mostly in 3 0 UTRs of protein coding genes ( Figure 1A) . Interestingly, this binding mode is very different from that of TDP-43 and FUS, which bind primarily to long introns of pre-mRNAs and bind to thousands of transcripts in the CNS (LagierTourenne et al., 2012; Polymenidou et al., 2011) .
Another interesting difference between hnRNPA2B1 and TDP-43/FUS was revealed when Martinez and colleagues addressed the in vivo function of hnRNPA2B1 in the CNS: using both microarray and RNA-seq, they analyzed gene expression changes upon antisense oligonucleotide (ASO)-mediated depletion of hnRNPA2B1 in the mouse spinal cord. They found that only a very small number of mRNAs (<30, e.g., those encoding for the splicing factors hnRNPA1, hnRNPH1, or SRSF7) showed altered levels upon hnRNPA2B1 depletion ( Figure 1A) . In stark contrast, depletion of TDP-43 and FUS causes widespread changes in transcript levels in the nervous system (Lagier-Tourenne et al., 2012; Polymenidou et al., 2011) .
Interestingly, >80 mRNAs showed a shift in their polyadenylation site upon depletion of hnRNPA2B1 ( Figure 1A ). This effect is most likely mediated by direct binding of hnRNPA2B1, as about half of the mRNAs with altered polyA sites carry a UAG(G/A) motif in their 3 0 UTR. 3 0 UTRs often harbor key signals determining RNA fate, e.g., RNA trafficking or stability. Therefore, analyzing the functional consequences of alternative poly(A) sites in select target mRNAs might reveal interesting downstream functions of hnRNPA2B1.
The strongest impact of hnRNPA2B1 depletion in spinal cord, however, appears to be on alternative splicing (AS; 276 changes identified by splicing-sensitive microarrays) ( Figure 1A ). Especially alternative cassette exons were frequently skipped (repressed) upon hnRNPA2B1 depletion. Interesting AS events include an alternative cassette exon in the 3 0 UTR of hnRNPA2B1 itself, causing autoregulation of hnRNPA2B1, and cassette exons in several ALS-associated genes, e.g., D-amino acid oxidase (Dao) and Ataxin-2 (Atxn2) ( Figure 1A ). The authors further analyzed the functional consequences of hnRNPA2B1 depletion on their top hit, Dao, and found that loss of hnRNPA2B1 
